834 related articles for article (PubMed ID: 22466288)
1. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism.
Herman MA; Peroni OD; Villoria J; Schön MR; Abumrad NA; Blüher M; Klein S; Kahn BB
Nature; 2012 Apr; 484(7394):333-8. PubMed ID: 22466288
[TBL] [Abstract][Full Text] [Related]
2. Islet ChREBP-β is increased in diabetes and controls ChREBP-α and glucose-induced gene expression via a negative feedback loop.
Jing G; Chen J; Xu G; Shalev A
Mol Metab; 2016 Dec; 5(12):1208-1215. PubMed ID: 27900263
[TBL] [Abstract][Full Text] [Related]
3. Absence of Carbohydrate Response Element Binding Protein in Adipocytes Causes Systemic Insulin Resistance and Impairs Glucose Transport.
Vijayakumar A; Aryal P; Wen J; Syed I; Vazirani RP; Moraes-Vieira PM; Camporez JP; Gallop MR; Perry RJ; Peroni OD; Shulman GI; Saghatelian A; McGraw TE; Kahn BB
Cell Rep; 2017 Oct; 21(4):1021-1035. PubMed ID: 29069585
[TBL] [Abstract][Full Text] [Related]
4. Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice.
Jois T; Chen W; Howard V; Harvey R; Youngs K; Thalmann C; Saha P; Chan L; Cowley MA; Sleeman MW
Mol Metab; 2017 Nov; 6(11):1381-1394. PubMed ID: 29107286
[TBL] [Abstract][Full Text] [Related]
5. ChREBP regulates fructose-induced glucose production independently of insulin signaling.
Kim MS; Krawczyk SA; Doridot L; Fowler AJ; Wang JX; Trauger SA; Noh HL; Kang HJ; Meissen JK; Blatnik M; Kim JK; Lai M; Herman MA
J Clin Invest; 2016 Nov; 126(11):4372-4386. PubMed ID: 27669460
[TBL] [Abstract][Full Text] [Related]
6. Decreased transcription of ChREBP-α/β isoforms in abdominal subcutaneous adipose tissue of obese adolescents with prediabetes or early type 2 diabetes: associations with insulin resistance and hyperglycemia.
Kursawe R; Caprio S; Giannini C; Narayan D; Lin A; D'Adamo E; Shaw M; Pierpont B; Cushman SW; Shulman GI
Diabetes; 2013 Mar; 62(3):837-44. PubMed ID: 23209190
[TBL] [Abstract][Full Text] [Related]
7. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism.
Tang Y; Wallace M; Sanchez-Gurmaches J; Hsiao WY; Li H; Lee PL; Vernia S; Metallo CM; Guertin DA
Nat Commun; 2016 Apr; 7():11365. PubMed ID: 27098609
[TBL] [Abstract][Full Text] [Related]
8. Modulation of carbohydrate response element-binding protein gene expression in 3T3-L1 adipocytes and rat adipose tissue.
He Z; Jiang T; Wang Z; Levi M; Li J
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E424-30. PubMed ID: 15100094
[TBL] [Abstract][Full Text] [Related]
9. De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health.
Eissing L; Scherer T; Tödter K; Knippschild U; Greve JW; Buurman WA; Pinnschmidt HO; Rensen SS; Wolf AM; Bartelt A; Heeren J; Buettner C; Scheja L
Nat Commun; 2013; 4():1528. PubMed ID: 23443556
[TBL] [Abstract][Full Text] [Related]
10. Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity.
Bindesbøll C; Fan Q; Nørgaard RC; MacPherson L; Ruan HB; Wu J; Pedersen TÅ; Steffensen KR; Yang X; Matthews J; Mandrup S; Nebb HI; Grønning-Wang LM
J Lipid Res; 2015 Apr; 56(4):771-85. PubMed ID: 25724563
[TBL] [Abstract][Full Text] [Related]
11. FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin Resistance.
Nuotio-Antar AM; Poungvarin N; Li M; Schupp M; Mohammad M; Gerard S; Zou F; Chan L
Endocrinology; 2015 Nov; 156(11):4020-32. PubMed ID: 26248218
[TBL] [Abstract][Full Text] [Related]
12. ChREBP-Mediated Regulation of Lipid Metabolism: Involvement of the Gut Microbiota, Liver, and Adipose Tissue.
Iizuka K; Takao K; Yabe D
Front Endocrinol (Lausanne); 2020; 11():587189. PubMed ID: 33343508
[TBL] [Abstract][Full Text] [Related]
13. The Roles of Carbohydrate Response Element Binding Protein in the Relationship between Carbohydrate Intake and Diseases.
Iizuka K
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769488
[TBL] [Abstract][Full Text] [Related]
14. ChREBP, a glucose-responsive transcriptional factor, enhances glucose metabolism to support biosynthesis in human cytomegalovirus-infected cells.
Yu Y; Maguire TG; Alwine JC
Proc Natl Acad Sci U S A; 2014 Feb; 111(5):1951-6. PubMed ID: 24449882
[TBL] [Abstract][Full Text] [Related]
15. Recent progress on the role of ChREBP in glucose and lipid metabolism.
Iizuka K
Endocr J; 2013; 60(5):543-55. PubMed ID: 23604004
[TBL] [Abstract][Full Text] [Related]
16. The Glucose Sensor ChREBP Links De Novo Lipogenesis to PPARγ Activity and Adipocyte Differentiation.
Witte N; Muenzner M; Rietscher J; Knauer M; Heidenreich S; Nuotio-Antar AM; Graef FA; Fedders R; Tolkachov A; Goehring I; Schupp M
Endocrinology; 2015 Nov; 156(11):4008-19. PubMed ID: 26181104
[TBL] [Abstract][Full Text] [Related]
17. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
18. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
[TBL] [Abstract][Full Text] [Related]
19. Expression of the insulin-responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor alpha.
Dalen KT; Ulven SM; Bamberg K; Gustafsson JA; Nebb HI
J Biol Chem; 2003 Nov; 278(48):48283-91. PubMed ID: 12970362
[TBL] [Abstract][Full Text] [Related]
20. Identification of HNF-4α as a key transcription factor to promote ChREBP expression in response to glucose.
Meng J; Feng M; Dong W; Zhu Y; Li Y; Zhang P; Wu L; Li M; Lu Y; Chen H; Liu X; Lu Y; Sun H; Tong X
Sci Rep; 2016 Mar; 6():23944. PubMed ID: 27029511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
